News

NextGen Healthcare Launches AI-Driven Efficiency Solution for Mental and Behavioral Health Professionals

Company to Showcase NextGen® Ambient Assist for Behavioral Health April 15-17 at NatCon 2024REMOTE-FIRST COMPANY/ST. LOUIS--(BUSINESS WIRE)--#NextGenHealthcare--As the healthtech industry…

2 years ago

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit

Shaping the Future of Aesthetic Treatments with Advanced Medical TechnologyCLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”; “Company”), the…

2 years ago

VitalHub Corp. Closes $40.25 Million Bought Deal Public Offering with Full Exercise of Over-Allotment Option

Toronto, Ontario--(Newsfile Corp. - April 11, 2024) - VitalHub Corp. (TSX: VHI) (the "Company" or "VitalHub") is pleased to announce…

2 years ago

Akanda Corp. Announces Closing of the Sale of RPK

London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 1, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the…

2 years ago

Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB(R) at NATA24 Annual Symposium

HENNINGSDORF, GERMANY / ACCESSWIRE / April 11, 2024 / Lindis Blood Care, a company aiming to set a new standard…

2 years ago

Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC),…

2 years ago

Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

SEATTLE, WA / ACCESSWIRE / April 11, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing…

2 years ago

Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market

$59 million financing includes participation from new Icelandic institutional and existing investors; Extends cash runway until 2H 2026 The Central…

2 years ago

The International Myeloma Foundation and Black Swan Research Initiative® Announce the Release of New iStopMM Cohort Study: A Multivariable Prediction Model for Bone Marrow Sampling on Individuals with MGUS

STUDIO CITY, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and Black Swan Research Initiative® (BSRI)…

2 years ago

10 Barrel Brewing Adds ‘Juicy Drama’ to Its Award-Winning HopBurst Family

BEND, Ore., April 11, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. (“10 Barrel”), an award-winning pioneer in the craft…

2 years ago